Toby Maher, ERS 2019 – Pirfenidone in Patients with Progressive Fibrosing Unclassifiable ILD Touch Medical Media Services 3:07 4 years ago 1 333 Скачать Далее
Toby Maher, ERS 2019 – Pirfenidone in Patients with Progressive Fibrosing Unclas1 Bolton Pulmonary Fibrosis Support Group 3:07 2 years ago 24 Скачать Далее
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease The France Foundation 1:59 4 years ago 3 253 Скачать Далее
Exploring Antifibrotic Therapy in Patients with Autoimmune Associated ILD The France Foundation 3:15 4 years ago 236 Скачать Далее
Should Unclassifiable ILD be Treated like IPF? | Joao A. de Andrade, MD Pulmonary Fibrosis Foundation 18:36 4 years ago 552 Скачать Далее
Progressive Fibrosing Interstitial Lung Disease: Shining a Light on the Latest Clinical Advances PeerView CME 19:42 5 years ago 899 Скачать Далее
Safety and Management of Side Effects of Pirfenidone and Nintedanib | Wendi Mason, MSN Pulmonary Fibrosis Foundation 15:22 6 years ago 8 538 Скачать Далее
When shall a patient who is diagnosed with IPF initiate treatment? Boehringer Ingelheim Idiopathic Pulmonary Fibrosis 0:43 8 years ago 697 Скачать Далее
My physician talks about IPF progression. What does he mean? Boehringer Ingelheim Idiopathic Pulmonary Fibrosis 0:50 8 years ago 6 204 Скачать Далее
Impact Of Patient Education And Follow Up With Pirfenidone In Patients With IPF The France Foundation 3:12 3 years ago 590 Скачать Далее
Nice Update on Nintedanib for ILD Patients Steve Jones Action for Pulmonary Fibrosis Bolton Pulmonary Fibrosis Support Group 5:32 2 years ago 705 Скачать Далее
Talking to patients diagnosed with IPF Boehringer Ingelheim Idiopathic Pulmonary Fibrosis 1:44 9 years ago 1 068 Скачать Далее
